Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome

Feng Xu(Nanchang University), Xiao Li(Anhui Agricultural University)

Oncotarget

January 23, 2016

10.18632/oncotarget.6992

Cited by 34

Related Papers

The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease

|Annals of Translational Medicine|2020|89

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

|Scientific Reports|2014|49

Interleukin‐17 enhances the production of interferon‐γ and tumour necrosis factor‐α by bone marrow <scp>T</scp> lymphocytes from patients with lower risk myelodysplastic syndromes

|European Journal Of Haematology|2013|36

Heat-Moisture Treatment Further Reduces In Vitro Digestibility and Enhances Resistant Starch Content of a High-Resistant Starch and Low-Glutelin Rice

|Foods|2021|34

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes

|iScience|2023|9